Evolva
Latest round
- Series B
Last raised
- Dec 2009
Total raised
- $71M
Investors
- 14
About Evolva
Evolva Holding SA is focused on the creation of natural ingredients, founded in 2004 in Reinach, Switzerland. for CHF 20 million on December 28, 2023. Following this acquisition, Evolva AG will be delisted from the SIX Swiss Exchange.Evolva Holding SA specializes in the development and commercialization of innovative natural ingredients across various sectors, particularly in food, beverages, and health. The company’s main products comprise biosynthetic flavors and fragrances, which enhance the sensory appeal of food and beverages while emphasizing sustainable practices., Evolva Holding SA aims to leverage the funds from the CHF 20 million deal to enhance its product offerings and expand into additional markets. The company will focus on launching new biosynthetic ingredients and increasing its presence in North America and Europe. The management anticipates that the strategic integration with Lallemand will facilitate further growth opportunities and market expansion.
Who invested in Evolva
14 investors across 5 rounds
See all investors in Evolva
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Evolva
Who invested in Evolva?
Evolva has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evolva raised?
Evolva has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Evolva last raise money?
Evolva's most recent round on record is a Series B, in Dec 2009.
What does Evolva do?
Evolva Holding SA is focused on the creation of natural ingredients, founded in 2004 in Reinach, Switzerland.
Where is Evolva headquartered?
Evolva is headquartered in Reinach, Switzerland.
Which VCs invest in companies like Evolva?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Evolva's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Evolva? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.